Ушбу иш иқтибос қилган ишлар

112 та иш

Иш: The efficacy of probiotics, prebiotics, and synbiotics in depression and anxiety: an umbrella review of clinical trials

1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

   Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt +23

   Мақола202155 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.080154

2. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

   Julian P. T. Higgins, Doug Altman, Peter C Gøtzsche +9

   Мақола20119 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.074666

3. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

   Ygor Parladore Silva, Andressa Bernardi, Rudimar Luiz Frozza

   Шарҳ мақола20203 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.480508

4. The Role of BDNF on Neural Plasticity in Depression

   Tao Yang, Zheng Nie, Haifeng Shu +5

   Мақола20203 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.743308

5. Dual role of nitric oxide in Alzheimer's disease

   Ali Azargoonjahromi

   Шарҳ мақола20233 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.785466

6. The Impact of Microbiota on Brain and Behavior: Mechanisms & Therapeutic Potential

   Yuliya Borre, Rachel D. Moloney, Gerard Clarke +2

   Шарҳ мақола20143 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.798515

7. Vagal Pathways for Microbiome-Brain-Gut Axis Communication

   Paul Forsythe, John Bienenstock, Wolfgang Kunze

   Шарҳ мақола20143 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.798555

8. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

   Beverley Shea, Barnaby C Reeves, George A. Wells +8

   Мақола20173 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.876244

9. BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity

   Przemysław Kowiański, Grażyna Lietzau, Ewelina Czuba +3

   Шарҳ мақола20172 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.147117

10. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome

    Paulina Markowiak‐Kopeć, Katarzyna Śliżewska

    Шарҳ мақола20202 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.220094

11. The effects of probiotics on depressive symptoms in humans: a systematic review

    Caroline Wallace, Roumen Milev

    Шарҳ мақола20172 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.220822

12. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Мақола20222 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.440551

13. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications

    Jennifer C. Felger, Frank Lotrich

    Шарҳ мақола20132 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.756047

14. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903040

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903041

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903042

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903043

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903044

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903045

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903046

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903047

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903048

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903049

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903050

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.903051